| 1/3 | US=85 / Biol/Mol Leprêtre C, Sidoli G, Scovassi AI, Torriglia A. Leukocyte elastase inhibitor. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 25-31. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. INIBIDOR DE ELASTASE DE LEUCOCITOS; APOPTOSE; L-DNASE II; LEI; PARP-1; POLI ADP-RIBOSILACAO |
| 2/3 | US=14 / Câncer Drew Y, Calvert H. The potential of PARP inhibitors in genetic breast and ovarian cancers. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 136-45. ISBN 978-1-57331-700-9. CANCER DE MAMA; CANCER DE OVARIO; GENE BCRA1; GENE BCRA2; GENETICA DO CANCER; ADP-RIBOSILACAO; POLIMERASE-1; PARP-1; INIBIDORES DE PARP-1 |
| 3/3 | US=56 / Biol/Mol Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 13-21. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. CASPASE-3; APOPTOSE; ESTRESSE GENOTOXICO; IRRADIACAO; PARP-1; CITOMETRIA DE FLUXO; IMUNOHISTOQUIMICA |